This Wall Street Journal article highlights a critical flaw in our health care system: the enormous disparity in prescription drug prices, driven by a system where middlemen profit while American families and businesses bear the cost.
The article revealed staggering examples of drug pricing inconsistencies:
-Medicare drugs with prices that range by thousands of dollars depending on the plan and location.
-Generic prostate-cancer drugs that cost $815 in one county but surge to $3,356 in another.
-Seniors forced to dip into retirement savings or find part-time jobs just to afford life-saving medications.
This isn’t just an isolated issue affecting public safety nets like Medicare—it’s a broken, profit-driven system that impacts private markets too. Patients are paying more than they should while losing access to some of the care they need.
𝐈𝐭’𝐬 𝐜𝐨𝐬𝐭𝐢𝐧𝐠 𝐮𝐬 𝐢𝐧 𝐦𝐨𝐧𝐞𝐲, 𝐚𝐜𝐜𝐞𝐬𝐬, 𝐚𝐧𝐝 𝐡𝐞𝐚𝐥𝐭𝐡—𝐚𝐧𝐝 𝐢𝐭 𝐬𝐡𝐨𝐮𝐥𝐝𝐧’𝐭 𝐛𝐞 𝐭𝐡𝐢𝐬 𝐰𝐚𝐲.
We believe there’s a better approach—one that prioritizes transparency, equitable pricing and patient care over profit margins. It's time to address this systemic dysfunction. Let's move toward a future where healthcare serves the people, not profit-first conglomerates.
What changes do you think are most urgently needed? Share your thoughts below.
Article link: https://lnkd.in/gwSuKdXk